Skip to main content
Download PDF

Comparison of the six-minute walk test performed over a 15 and 30 m course by children with cerebral palsy

BMC Musculoskeletal Disorders volume 24, Article number: 34 (2023) Cite this article

Abstract

Background

The aim of this study was to compare performance on the six-minute walk test (6MWT) performed over 15 m and 30 m courses by children and youths with cerebral palsy (CP).

Methods

Children and youths with CP at Gross Motor Function Classification System levels I–IV performed the 6MWT in a straight 15 m-long corridor (first trial) and 30 m-long corridor (second trial). The intraclass correlation coefficient (ICC) and Bland-Altman plots were used to evaluate the agreement between the 6MWT results for the two corridor lengths.

Results

We included 82 children and youths with CP (36 girls, 46 boys), with a mean age of 11.7 years (SD 4.2, range 5–22 years). There was high agreement between the results of the two 6MWTs: ICC 0.93 (95% confidence interval 0.76–0.97). The total walking distance was longer for the 30 m course (median 399 m, range 44–687 m) than the 15 m course (median 357 m, range 24–583 m).

Conclusions

We observed good agreement for the performance of the 6MWT in the 15 m and 30 m courses, although the total walking distance was greater for the 30 m course. We recommend that the same distance is used when evaluating changes in walking ability for an individual child. Both distances are appropriate when measuring endurance in children and youths with CP.

Peer Review reports

Background

Cerebral palsy (CP) is caused by a nonprogressive brain injury early in life and affects primarily movement and posture but can also cause activity limitations [1]. Children with CP are usually born without deformities, but secondary musculoskeletal complications tend to develop in childhood and increase in severity with time. CP is associated with musculoskeletal and neurological disorders that affect a child’s motor function, walking ability, and gait pattern [2], which can also impair endurance [3]. Children with CP are less physically active than their peers [4,5,6]. According to the International Classification of Functioning (ICF), walking disabilities and reduced physical activity can limit participation by children with disabilities [7,8,9,10,11].

Field walking tests are commonly used to evaluate exercise capacity in clinical practice [12]. These tests are simple and easy to perform, and do not require any special equipment. The six-minute walk test (6MWT) is a submaximal exercise test used to assess aerobic capacity and endurance, and to indicate an individual’s functional capacity for daily physical activity [13]. Holland et al. compiled a standard operating procedure for the 6MWT in patients with chronic respiratory diseases. The test should be performed along a flat, straight course with a hard surface measuring at least 30 m in length [12]. However, it can be challenging to find a suitable 30 m stretch in an indoor clinical setting. The recommendations given by the American Thoracic Society (ATS) as guidelines for the 6MWT were not intended to limit the use of alternative protocols for research studies [13]. Thus, the literature contains several modifications of the 6MWT in terms of conditions (indoor or outdoor [14]), distance (20–50 m [15,16,17]), and patients’ medical conditions (cardiac, pulmonary, or neurological disorders [18,19,20]).

The 6MWT is a reliable test for children with CP [21]. Studies show that age and gross motor function correlate with 6MWT performance in children with CP [22, 23]. Maher et al. [24] evaluated the reliability of the 6MWT in young ambulant people with CP. However, their results were based on a test performed on a 10 m course. Differences in the course distance can lead to variability and affect the reliability of the measurements. The aim of this study was to compare 6MWT performance when performed by children and youths with CP over 15 m and 30 m courses.

Methods

The 6MWT was performed by children and adolescents with CP at Gross Motor Function Classification System (GMFCS) levels I–IV. They were recruited at the Rehabilitation Centre, Department of Pediatric Orthopedics and Traumatology, Poznan University of Medical Sciences, Poland, between 25 November 2019 and 21 January 2020.

The inclusion criteria were a diagnosis of CP, the ability to walk independently with or without a device for 6 min (no assistance was required with turning or steering), and the ability to understand and follow instructions. The exclusion criteria were the inability to walk or acute pain that could affect ambulation at the time of the examination.

For all patients, the 15 m 6MWT trial was performed on the first day of a 2-week rehabilitation training program, and the 30 m distance trial was performed at the same time of day on the second day. Both tests were performed before any rehabilitation training began. All examinations and testing were administered by six physiotherapists, who supervise the 6MWT regularly, and using an established protocol.

The 6MWT was performed indoors, on a flat, straight, hard-surfaced 15 m-long corridor (first trial) and a 30 m-long corridor (second trial). The length of the walking course was lined by tape every 3 m. The turnaround points were indicated by orange cones at both ends of the course. The children and adolescents wore appropriate comfortable shoes for walking and used their orthoses or usual walking aids (cane, walker, etc.) during both the first and second trials. Before each test, the participant sat in a chair and relaxed for 10 min. No warm-up was performed.

Before the test, the examiner instructed the participants about completing the test, including the statement, “You should walk as fast as you can, but not run.” Each participant was then asked to walk the course between the cones for 6 min. The examiner cautioned the participants not to run but encouraged them with standardized phrases such as, “You are doing a great job!” and “Keep going!”. During the trial, the participants were permitted to stop or slow down and to resume walking as soon as possible, but the timer was not stopped. The final length of the trial was calculated by counting the number of laps and calculating the measured distance from the starting position to the stopping point in meters.

The study was approved by the ‘Ethical Committee’ of Poznan University of Medical Sciences (nr 244/20). All the methods were performed under relevant guidelines and regulations or under Declaration of Helsinki. Parents or legal guardians of each patient enrolled into the study signed the written consent form.

Statistical analysis

The intraclass correlation coefficient (ICC) [25] with the two-way random and absolute agreement definition was used to evaluate the agreement between the 6MWT performance for the 15 and 30 m courses. The mean with standard deviation (SD), median with range, standard error of the differences with 95% confidence intervals (CI) were used to analyze systematic differences between the two distances. Bland-Altman plots [26] were used to estimate the difference between the two distances against their mean, with limits of agreement based on ±2 SD. IBM SPSS Statistics (version 26.0) was used for all statistical analyses.

Results

We included 82 children and youths with CP classified at GMFCS levels I–IV; 36 were girls and 46 were boys. Their age range was 5–22 years (mean age 11.7 years [SD 4.2]) (Table 1).

Table 1 Characteristics of the participants
Full size table

There was a high agreement between the results of the 6MWT over the 15 and 30 m courses: ICC 0.93 (95% CI 0.76–0.97). The median total distances were 399 m (range 44–687 m) for the 30 m course and 357 m (range 24–583 m) for the 15 m course (Table 2). The same was observed within all GMFCS levels; that is, the median distances walked were longer when using the 30 m than the 15 m corridor (Table 3).

Table 2 Total walking distance (m) in the 6MWT over the 30 m and 15 m courses
Full size table
Table 3 Total walking distance (m) in the 6MWT by children at GMFCS levels I–IV over the 30 m and 15 m courses
Full size table

The mean difference between 15 and 30 m distances was − 34.91 (95% CI −45.31 to −24.51), SD 47.34 m, and standard error 5.23. Bland-Altman plots of differences against mean ± 2 SD for the two methods indicate that some children with the lowest average distances performed better at the 15-m distance, while the opposite was seen for most children with higher average distances (Fig. 1).

Fig. 1
figure 1

Bland-Altman plots of differences against mean with limits of agreement of ±2 standard deviations

Full size image

Discussion

We found a high level of agreement in 6MWT performance between the 15 m and 30 m walking courses in children and youths with CP. Even though most children preformed slightly better at the 30 m course, some children with lower scores on the 6MWT (typically GMFCS IV) seemed to perform slightly better at the 15 m course. The participants in this study represented different ages and GMFCS levels (I–IV). All participants were ambulant and were allowed to use their usual walking aids, orthotics, and shoes during the tests. Previous studies have reported on the utility of the 6MWT in people with CP. Fitzgerald et al. [27] described a reference range of values in ambulant children with spastic CP at GMFCS levels I–III and their healthy peers. The main modification from the original ATS protocol was a 70 m walking trail. We found a slightly different distribution of values across the GMFCS levels than those reported by Fitzgerald et al. Fiss et al. [22] reported on the developmental trajectories and reference percentiles for the 6MWT in 3–12-year-old children with CP at GMFCS levels I–III. Even though the participants in our study were older, the results were consistent with the developmental trajectories noted by Fiss et al. [22].

We could not find any studies evaluating agreement between the 6MWT at two different distances for children with CP. However, a previous study by Sciurba et al. [28] involved 761 participants who performed the 6MWT at 17 clinical centers after lung volume reduction surgery. The performance on the test varied according to the dimensions of the walking trail. The authors concluded that patients achieved a longer distance on the longer courses. Our finding is consistent with this result. However, Sciurba et al. [28] noted that it seems less important to standardize the length of the course provided it exceeds the minimum of 50 ft, which is around 15 m.

In our study, 70% of participants improved their walking distance on the second day, which may reflect a learning effect, as reported by Jay et al. [29] and Trooster et al. [17]. Jay et al. [29] analyzed data collected from a population-based study involving 3805 individuals using a 100-ft course and observed a mean 15% improvement when the test was performed on two successive days. However, they noted that this effect is not important when determining cross-sectional correlations or when using the results as a baseline predictor of later events. Trooster et al. [17] reported a similar learning effect in a study of 51 healthy subjects who performed the 6MWT twice on a 50 m course with 2.5 h between the two tests. The distance covered on the second test was on average 8% greater than on the first test.

The protocol of the 6MWT should be standardized in terms of encouragement. The positive effect of encouragement in the 6MWT was reported by Guyatt et al. [30], who found that encouragement given every 30 s during the walking test was associated with a significant increase in the distance walked. Jay et al. [29] concluded that a longer distance may be expected when non-standardized encouragement is given. To reduce potential effects of non-standardized encouragement, we used a standardized protocol where encouragement was given every 10 seconds to all children on both occasions.

One limitation of this study was that the 30 m test was performed the day after the 15 m test in all participants. The systematically longer distance covered in the 30 m test may reflect the effects of a longer course or a learning effect, or both. However, the aim of this study was to determine the agreement between tests over these two distances, which was shown to be high. Another limitation of this study was the use of an indoor space that was unfamiliar to the participants. An unfamiliar setting can influence children, especially those with disabilities. Patients walking in a gait laboratory may have a different gait pattern from that observed by parents or caregivers at home. Therefore, assessment of walking distance should preferably be performed in a natural environment using a portable device [31].

Conclusions

Walking tests are a part of the assessment of children with CP. It is important to consider the results of assessments such as the clinical examination and gait analysis when making decisions about surgical treatment and rehabilitation. This study showed a high agreement between the 6MWT performed on 15 m and 30 m courses in children and youths with CP. The total walking distance may be slightly shorter when the test is performed over a 15 m course. Therefore, we recommend that the same distance is used when evaluating potential changes for an individual child. Our findings suggest that both tests are appropriate and reliable methods when measuring endurance in children and youths with CP.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Abbreviations

CP:

Cerebral palsy

6MWT:

Six-minute walk test

ATS:

American Thoracic Society

GMFCS:

Gross Motor Function Classification System

ICC:

Intraclass correlation coefficient

SD:

Standard deviation

References

  1. (2007), The Definition and Classification of Cerebral Palsy. Developmental Medicine & Child Neurology, 49: 1-44. https://doi.org/10.1111/j.1469-8749.2007.00001.x

  2. Rodda J, Graham HK. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur J Neurol. 2001;8(Suppl 5):98–108.

    Article  Google Scholar 

  3. Jeffries L, Fiss A, McCoy SW, Bartlett DJ. Description of primary and secondary impairments in Young children with cerebral palsy. Pediatr Phys Ther. 2016;28(1):7–14.

    Article  Google Scholar 

  4. van den Berg-Emons HJ, Saris WH, de Barbanson DC, Westerterp KR, Huson A, van Baak MA. Daily physical activity of schoolchildren with spastic diplegia and of healthy control subjects. J Pediatr. 1995;127(4):578–84.

    Article  Google Scholar 

  5. Bell KL, Davies PS. Energy expenditure and physical activity of ambulatory children with cerebral palsy and of typically developing children. Am J Clin Nutr. 2010;92(2):313–9.

    Article  CAS  Google Scholar 

  6. Dallmeijer AJ, Brehm MA. Physical strain of comfortable walking in children with mild cerebral palsy. Disabil Rehabil. 2011;33(15-16):1351–7.

    Article  Google Scholar 

  7. King G, Law M, King S, Rosenbaum P, Kertoy MK, Young NL. A conceptual model of the factors affecting the recreation and leisure participation of children with disabilities. Phys Occup Ther Pediatr. 2003;23(1):63–90.

    Article  Google Scholar 

  8. Law M, King G, King S, Kertoy M, Hurley P, Rosenbaum P, et al. Patterns of participation in recreational and leisure activities among children with complex physical disabilities. Dev Med Child Neurol. 2006;48(5):337–42.

    Article  Google Scholar 

  9. Michelsen SI, Flachs EM, Uldall P, Eriksen EL, McManus V, Parkes J, et al. Frequency of participation of 8-12-year-old children with cerebral palsy: a multi-Centre cross-sectional European study. Eur J Paediatr Neurol. 2009;13(2):165–77.

    Article  Google Scholar 

  10. Palisano RJ, Chiarello LA, King GA, Novak I, Stoner T, Fiss A. Participation-based therapy for children with physical disabilities. Disabil Rehabil. 2012;34(12):1041–52.

    Article  Google Scholar 

  11. Frisch D, Msall ME. Health, functioning, and participation of adolescents and adults with cerebral palsy: a review of outcomes research. Dev Disabil Res Rev. 2013;18(1):84–94.

    Article  Google Scholar 

  12. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.

    Article  Google Scholar 

  13. ATS statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166(1):111–7. https://doi.org/10.1164/ajrccm.166.1.at1102.

  14. Fiss AL, Jeffries L, Yocum A, Westcott McCoy S. On track study T: validity of the early activity scale for endurance and the 6-minute walk test for children with cerebral palsy. Pediatr Phys Ther. 2019;31(2):156–63.

    Article  Google Scholar 

  15. O'Keeffe ST, Lye M, Donnellan C, Carmichael DN. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart. 1998;80(4):377–82.

    Article  CAS  Google Scholar 

  16. Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardpulm Rehabil. 2001;21(2):87–93.

    Article  CAS  Google Scholar 

  17. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14(2):270–4.

    Article  CAS  Google Scholar 

  18. Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Ther Adv Cardiovasc Dis. 2019;13:1753944719870084.

    Article  Google Scholar 

  19. Reychler G, Boucard E, Peran L, Pichon R, Le Ber-Moy C, Ouksel H, et al. One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patients. Clin Respir J. 2018;12(3):1247–56.

    Article  Google Scholar 

  20. Vita GL, Stancanelli C, Gentile L, Barcellona C, Russo M, Di Bella G, et al. 6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR). Neuromuscul Disord. 2019;29(3):213–20.

    Article  Google Scholar 

  21. Nsenga Leunkeu A, Shephard RJ, Ahmaidi S. Six-minute walk test in children with cerebral palsy gross motor function classification system levels I and II: reproducibility, validity, and training effects. Arch Phys Med Rehabil. 2012;93(12):2333–9.

    Article  Google Scholar 

  22. Fiss AL, Jeffries L, Bjornson K, Avery L, Hanna S, Westcott McCoy S. Developmental trajectories and reference percentiles for the 6-minute walk test for children with cerebral palsy. Pediatr Phys Ther. 2019;31(1):51–9.

    Article  Google Scholar 

  23. Thompson P, Beath T, Bell J, Jacobson G, Phair T, Salbach NM, et al. Test-retest reliability of the 10-metre fast walk test and 6-minute walk test in ambulatory school-aged children with cerebral palsy. Dev Med Child Neurol. 2008;50(5):370–6.

    Article  Google Scholar 

  24. Maher CA, Williams MT, Olds TS. The six-minute walk test for children with cerebral palsy. Int J Rehabil Res. 2008;31(2):185–8.

    Article  Google Scholar 

  25. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1(1):30–46.

    Article  Google Scholar 

  26. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

    Article  CAS  Google Scholar 

  27. Fitzgerald D, Hickey C, Delahunt E, Walsh M, O’Brien T. Six-minute walk test in children with spastic cerebral palsy and children developing typically. Pediatr Phys Ther. 2016;28(2):192–9.

    Article  Google Scholar 

  28. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, et al. National Emphysema Treatment Trial Research G: six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003;167(11):1522–7.

    Article  Google Scholar 

  29. Jay SJ. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1396.

    Article  CAS  Google Scholar 

  30. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, et al. Effect of encouragement on walking test performance. Thorax. 1984;39(11):818–22.

    Article  CAS  Google Scholar 

  31. Carcreff L, Gerber CN, Paraschiv-Ionescu A, De Coulon G, Newman CJ, Aminian K, et al. Comparison of gait characteristics between clinical and daily life settings in children with cerebral palsy. Sci Rep. 2020;10(1):2091.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank all participants in this study.

Funding

Open access funding provided by Lund University. This study was supported by grants from Stiftelsen för Bistånd åt Rörelsehindrade i Skåne. The funding source had no influence on any part of the study or in the decision to submit the article for publication.

Author information

Authors and Affiliations

  1. Department of Pediatric Orthopedics and Traumatology, Poznan University of Medical Sciences, Poznań, Poland

    Joanna Krasny & Marek Jozwiak

  2. Department of Clinical Sciences Lund, Orthopaedics, Lund University, Lund, Sweden

    Elisabet Rodby-Bousquet

  3. Centre for Clinical Research, Uppsala University-Region Västmanland, Västerås, Sweden

    Elisabet Rodby-Bousquet

Authors
  1. Joanna Krasny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marek Jozwiak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabet Rodby-Bousquet
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JK designed the study, recruited the participants, collected the data, and drafted the manuscript. MJ designed the study, recruited the participants, and improved and revised the manuscript. ERB designed the study, analyzed the data, and improved and revised the manuscript. All authors approved the final draft.

Authors’ information

JK is a medical doctor and specialist in orthopedics in the Department of Pediatric Orthopedics and Traumatology, Poznan University of Medical Sciences, Poland. MJ, PhD, is a pediatric orthopedic surgeon and rehabilitation specialist, and Professor of Orthopedic Surgery and Division Head in the Department of Pediatric Orthopedics and Traumatology, Poznan University of Medical Sciences, Poland. ERB, PhD, is a physiotherapist and Associate Professor in the Department of Clinical Sciences, Orthopaedics, Lund University, and the Centre for Clinical Research, Uppsala University, Västerås, Sweden.

Corresponding author

Correspondence to Elisabet Rodby-Bousquet.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the ‘Ethical Committee’ of Poznan University of Medical Sciences (nr 244/20). All the methods were performed under relevant guidelines and regulations or under Declaration of Helsinki. Parents or legal guardians of each patient enrolled into the study signed the written informed consent form.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Krasny, J., Jozwiak, M. & Rodby-Bousquet, E. Comparison of the six-minute walk test performed over a 15 and 30 m course by children with cerebral palsy. BMC Musculoskelet Disord 24, 34 (2023). https://doi.org/10.1186/s12891-022-05944-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-022-05944-z

Keywords

  • Cerebral palsy
  • Children
  • Adolescents
  • Walking
  • Measurement

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us